Prices are updated after-hours
Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
crawled date : 2022 - 02 - 03    source : Www.biospace.com    save search
Syndax Pharmaceuticals Announces Transition of Michael A. Metzger to Chief Executive Officer; Briggs W. Morrison, M.D., to Assume Role of President, Head of Research & Development
Published: 2022-02-03 (Crawled : 23:00) - biospace.com/
SNDX | $20.82 1.61% 1.59% 850K twitter stocktwits trandingview |
Health Technology
 | | O: -0.89% H: 0.45% C: -2.81%
als ces research
Navidea Biopharmaceuticals Announces Settlement of Platinum Litigation; Receipt of Noncompliance Notice from NYSE American
Published: 2022-02-03 (Crawled : 23:00) - biospace.com/
NAVB | $0.035 50.69% 15K twitter stocktwits trandingview |
Health Technology
 | | O: 0.27% H: 0.0% C: -5.25%
america als biopharma ces set
Sierra Oncology Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares
Published: 2022-02-03 (Crawled : 23:00) - biospace.com/
SRRA | $54.99 0.04% 0.0% twitter stocktwits trandingview |
Health Technology
 | | O: -2.75% H: 1.8% C: -2.46%
ces
Silk Road Medical to Report Fourth Quarter and Full Year 2021 Financial Results on February 24, 2022
Published: 2022-02-03 (Crawled : 23:00) - biospace.com/
SILK | $17.32 -0.57% -0.58% 370K twitter stocktwits trandingview |
Health Technology
 | | O: -2.08% H: 6.62% C: -1.83%
financial results report results
Exelixis to Release Fourth Quarter and Full Year 2021 Financial Results on Thursday, February 17, 2022
Published: 2022-02-03 (Crawled : 23:00) - biospace.com/
EXEL | $22.51 0.09% 0.09% 2.3M twitter stocktwits trandingview |
Health Technology
 | | O: -0.39% H: 1.46% C: 0.56%
financial results results
AMGEN TO HOST VIRTUAL BUSINESS REVIEW MEETING
Published: 2022-02-03 (Crawled : 23:00) - biospace.com/
AMGN | $269.03 2.39% 2.33% 3.4M twitter stocktwits trandingview |
Health Technology
 | | O: 0.12% H: 0.15% C: -2.02%
LANNETT REPORTS FISCAL 2022 SECOND-QUARTER FINANCIAL RESULTS; REVISES DOWN FULL-YEAR GUIDANCE
Published: 2022-02-03 (Crawled : 23:00) - biospace.com/
LCI | $0.6855 0.0% 19K twitter stocktwits trandingview |
Health Technology
 | | O: 2.08% H: 0.0% C: -3.4%
financial results report results
Results of Single Center Study on Delcath’s CHEMOSAT® Hepatic Delivery System Published in Melanoma Research
Published: 2022-02-03 (Crawled : 23:00) - biospace.com/
DCTH | $4.87 3.73% 3.59% 300K twitter stocktwits trandingview |
Health Technology
 | | O: -2.04% H: 0.0% C: -2.78%
chemosat research liver system results
LIPOCINE ANNOUNCES ITS PARTNER RECEIVED FDA ACCEPTANCE OF NDA RESUBMISSION FOR TLANDO®
Published: 2022-02-03 (Crawled : 19:00) - biospace.com/
LPCN | $5.33 -2.02% -2.06% 11K twitter stocktwits trandingview |
Health Technology
 | | O: 0.0% H: 1.96% C: -2.02%
ATRS | $5.59 0.0% twitter stocktwits trandingview |
Health Technology
 | | O: -1.45% H: 1.47% C: -0.29%
tlando fda fda acceptance submission resubmission
Pasithea Therapeutics Initiates New Chemical Entity Drug Development Program in Multiple SclerosisCompany commences program to develop a tolerizing vaccine and names Hooke Laboratories as its research partner
Published: 2022-02-03 (Crawled : 17:00) - biospace.com/
KTTA | $7.15 -1.19% 540 twitter stocktwits trandingview |
| | O: 1.6% H: 0.0% C: -7.87%
multiple sclerosis program drug research therapeutics vaccine sclerosis
Applied DNA Schedules Fiscal 2022 First Quarter Financial Results Conference Call and Webcast for Thursday, February 10, 2022
Published: 2022-02-03 (Crawled : 16:00) - biospace.com/
APDN | $0.3396 0.59% 0.59% 85K twitter stocktwits trandingview |
Commercial Services
 | | O: 0.0% H: 1.75% C: -0.41%
financial results conference results
Antares Pharma Announces FDA Acceptance of NDA Resubmission for TLANDO®PDUFA target action date set for March 28, 2022
Published: 2022-02-03 (Crawled : 16:00) - biospace.com/
ATRS | $5.59 0.0% twitter stocktwits trandingview |
Health Technology
 | | O: -1.45% H: 1.47% C: -0.29%
tlando fda fda acceptance pdufa set submission resubmission
T2 Biosystems T2SARS-CoV-2™ Panel Detects Omicron Subvariants
Published: 2022-02-03 (Crawled : 16:00) - biospace.com/
TTOO A | $2.98 -0.33% -0.34% 34K twitter stocktwits trandingview |
Health Technology
 | | O: 0.0% H: 4.11% C: -3.25%
system sars-cov-2
scPharmaceuticals to Present at the 11th Annual SVB Leerink Global Healthcare Conference
Published: 2022-02-03 (Crawled : 16:00) - biospace.com/
SCPH | $4.55 0.89% 0.88% 170K twitter stocktwits trandingview |
Health Technology
 | | O: -2.07% H: 14.41% C: 10.59%
health als thc conference svb leerink global
J&J Incurs $610M Charge for Dropped Atopic Dermatitis Program
Published: 2022-02-03 (Crawled : 16:00) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M twitter stocktwits trandingview |
Health Technology
 | | O: 1.26% H: 0.0% C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M twitter stocktwits trandingview |
Health Technology
 | | O: -0.06% H: 0.0% C: 0.0%
atopic dermatitis program dermatitis drop charging
Kiromic BioPharma Announces Changes in Management, Board of Directors
Published: 2022-02-03 (Crawled : 15:30) - biospace.com/
KRBP | $2.5 -90.21% 830 twitter stocktwits trandingview |
Health Technology
 | | O: -8.26% H: 0.0% C: -13.3%
biopharma ces
Pharmazz Inc. submits Investigational New Drug Application to India Central Drugs Standard Control Organization for a Phase II clinical trial of sovateltide (PMZ-1620) in hypoxic-ischemic encephalopathy in neonates
Published: 2022-02-03 (Crawled : 15:30) - biospace.com/
AZZ | $74.8 -0.9% 0.0% 250K twitter stocktwits trandingview |
Producer Manufacturing
 | | O: -0.54% H: 1.35% C: 0.46%
pmz-1620 new drug application control drug trial india
Know Labs Receives IRB Approval to Begin Internal Clinical Trial of Non-Invasive Glucose Monitoring Technology Bio-RFID™
Published: 2022-02-03 (Crawled : 15:30) - biospace.com/
KNWN | $2.53 twitter stocktwits trandingview |
Manufacturing
 | | O: 0.0% H: 1.27% C: 0.63%
ABT | News | $107.28 1.91% 0.18% 10M twitter stocktwits trandingview |
Health Technology
 | | O: -1.08% H: 1.79% C: 1.15%
DXCM | $130.71 -2.67% -2.75% 2.8M twitter stocktwits trandingview |
Health Technology
 | | O: -0.98% H: 1.55% C: -2.94%
technology trial approval
Quotient Limited to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
Published: 2022-02-03 (Crawled : 15:30) - biospace.com/
QTNT | $0.38 2.73% -5.45% twitter stocktwits trandingview |
Health Technology
 | | O: -2.03% H: 4.83% C: -1.38%
diagnostic health conference life science
Gracell Biotechnologies to Participate in Citi 2022 Virtual Immuno-Oncology Summit
Published: 2022-02-03 (Crawled : 15:30) - biospace.com/
GRCL | $10.25 -0.29% 6.4M twitter stocktwits trandingview |
Manufacturing
 | | O: 1.68% H: 7.59% C: -4.62%
cel biotech iot
Gainers vs Losers
67% 33%

Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M twitter stocktwits trandingview |
Finance
EGOX | $0.0515 43.06% 30.1% 330M twitter stocktwits trandingview |

OLB 4 | $0.33 -14.95% 25.53% 840K twitter stocktwits trandingview |
Technology Services
NVFY | $2.77 31.28% 23.83% 33M twitter stocktwits trandingview |
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M twitter stocktwits trandingview |
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M twitter stocktwits trandingview |
Distribution Services
INSG | $3.03 25.21% 20.13% 330K twitter stocktwits trandingview |
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K twitter stocktwits trandingview |
Manufacturing
WLGS | News | $0.59 18.0% 17.9% 2.3M twitter stocktwits trandingview |

ASNS | $0.828 21.75% 17.86% 18K twitter stocktwits trandingview |

Your saved searches
Save your searches and get alerts when important news are released.